Fig. 1From: miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5BIRC5 is overexpressed in renal cell carcinoma. A Fifteen pairs of renal cell carcinoma (RCC) tissues and adjacent tissues were subjected to immunohistochemistry staining to characterize the level of survivin. B Statistical analysis. Analysis of the positive signal (IOD) of survivin in RCC and adjacent tissues using image pro plus 6.0. ****P < 0.0001. C qRT-PCR was performed to compare the mRNA expression of BIRC5 in RCC and adjacent tissues. The expression of BIRC5 was significantly upregulated in RCC tissuesBack to article page